Patient perceptions of multiple sclerosis and its treatment by de Seze J, Borgel F, Brudon F

Get full text

Treatment of Neuromyelitis Optica: Review and Recommendations. by Kimbrough, D, Fujihara, K, Jacob, A, Lana-Peixoto, M, Leite, M, Levy, M, Marignier, R, Nakashima, I, Palace, J, de Seze, J, Stuve, O, Tenembaum, SN, Traboulsee, A, Waubant, E, Weinshenker, BG, Wingerchuk, D

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease by Juryńczyk, M, Tackley, G, Kong, Y, Geraldes, R, Matthews, L, Woodhall, M, Waters, P, Kuker, W, Craner, M, Weir, A, DeLuca, G, Kremer, S, Leite, M, Vincent, A, Jacob, A, de Sèze, J, Palace, J

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing by Jarius, S, Paul, F, Aktas, O, Asgari, N, Dale, RC, De Seze, J, Franciotta, D, Fujihara, K, Jacob, A, Kim, HJ, Kleiter, I, Kümpfel, T, Levy, M, Palace, J, Ruprecht, K, Saiz, A, Trebst, C, Weinshenker, BG, Wildemann, B

Treatment of neuromyelitis optica: Review and recommendations by Kimbrough, D, Fujihara, K, Jacob, A, Lana-Peixoto, M, Isabel Leite, M, Levy, M, Marignier, R, Nakashima, I, Palace, J, De Seze, J, Stuve, O, Tenembaum, SN, Traboulsee, A, Waubant, E, Weinshenker, BG, Wingerchuk, D, Guthy Jackson Charitable Foundation Clinical Consortium and Biorepository

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset. by Collongues, N, Marignier, R, Jacob, A, Leite, M, Siva, A, Paul, F, Zephir, H, Akman-Demir, G, Elsone, L, Jarius, S, Papeix, C, Mutch, K, Saip, S, Wildemann, B, Kitley, J, Karabudak, R, Aktas, O, Kuscu, D, Altintas, A, Palace, J, Confavreux, C, De Seze, J

Characterization of NMO and NMOSD Patients with a Late Onset by Collongues, N, Marignier, R, Jacob, A, Siva, A, Paul, F, Zephir, H, Leite, M, Akman-Demir, G, Elsone, L, Jarius, S, Papeix, C, Mutch, K, Saip, S, Wildemann, B, Kitley, J, Karabudak, R, Aktas, O, Kuscu, D, Altintas, A, Palace, J, Confavreux, C, De Seze, J

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes by Juryńczyk, M, Weinshenker, B, Akman-Demir, G, Asgari, N, Barnes, D, Boggild, M, Chaudhuri, A, D’hooghe, M, Evangelou, N, Geraldes, R, Illes, Z, Jacob, A, Kim, H, Kleiter, I, Levy, M, Marignier, R, McGuigan, C, Murray, K, Nakashima, I, Pandit, L, Paul, F, Pittock, S, Selmaj, K, de Sèze, J, Siva, A, Tanasescu, R, Vukusic, S, Wingerchuk, D, Wren, D, Leite, I, Palace, J